You searched for "metastatic"
Macular Society chief executive, Cathy Yelf, announces retirement
After nearly a decade of dedicated service as chief executive of leading sight loss charity the Macular Society, Cathy Yelf has announced her decision to retire in 2024.Practical phacodynamics – making the most of your phacoemulsification machine
Understanding phacodynamics is appreciating the subtleties in the dynamic changes of the fluidics and the ultrasonic power delivered. Kristina Southcott explains. Increase my vacuum! Increase my bottle height! Increase my phaco power! I frequently observe the above commands being directed...Investigating the link between corneal clarity and statin use
2 February 2024
| Mohammad Nofal Usman, Nadia L Chaudhry
|
EYE - Cornea
Transparency is a vital attribute of the cornea, necessary in preserving healthy vision. Maintaining this requires the collective input of the various layers of the cornea. Mostly, the layers implicated in this are the corneal stroma and endothelium [1]. Our...
Global sight alliance declares climate emergency
22 April 2021
In recognition of Earth Day, on 22 April 2021, the International Agency for the Prevention of Blindness (IAPB) has declared a Climate Emergency and released a call to action for environmentally sustainable practices in the eye health sector.
A clinical review of optic neuropathy associated with amiodarone
1 August 2017
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Amiodarone, arrhythmia, optic neuropathy
The authors present a clinical overview of the occurrence of visual loss secondary to optic neuropathy associated with the use of the antiarrhythmic agent amiodarone. Amiodarone is prescribed for the management of atrial fibrillation and ventricular tachycardia / fibrillation. However,...
A case of progressive supranuclear palsy-like syndrome following aortic aneurysm repair
1 August 2015
| Claire Howard
|
EYE - Neuro-ophthalmology
This original article illustrates the case of an 18-year-old woman who developed progressive supranuclear palsy-like syndrome following an uneventful aortic aneurysm repair. The patient was unaffected for the first 48 hours after surgery and then developed dysarthria, dysphagia (requiring a...
Choroidal and macular thickness in nonarteritic anterior ischaemic optic neuropathy
1 December 2014
| Claire Howard
|
EYE - Neuro-ophthalmology
This study evaluates the choroidal and macular thickness in patients with chronic nonarteritic anterior ischaemic optic neuropathy (NA-AION). Two groups of subjects were compared, group one included 20 eyes with chronic NA-AION and group two, 31 healthy control eyes. The...
Ocular ischaemic syndrome in a rat model
1 December 2014
| Claire Howard
|
EYE - Neuro-ophthalmology
Ocular Ischaemic syndrome is a devastating eye disease caused by severe carotid stenosis. This study’s purpose was to develop a reliable rat model for this syndrome by subjecting rats to common carotid artery occlusion and sham surgery. Rats were assigned...
Comparison between findings in ‘active’ or ‘healed’ giant cell arteritis
29 March 2024
| Claire Howard
|
EYE - Neuro-ophthalmology
Giant cell arteritis (GCA) is the most common systemic vasculitis in older people and can cause devastating sight loss if untreated. Temporal artery biopsy is often relied upon for diagnosis by ophthalmologists, with a positive biopsy result indicating whether the...
Anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis: a retrospective medical records review
1 August 2024
| Claire Howard
|
EYE - Neuro-ophthalmology
Optic neuritis causes acute loss of visual function and can result in devastating visual dysfunction. Recently, measurements of anti-aquaporin 4 (AQP4) and anti-myelin oligodendrocyte glycoprotein (MOG) antibodies have become available, making it possible to evaluate the disease pathogenesis. This paper...
Addressing medical risk factors for diabetes and understanding the new systemic treatments
1 February 2014
| Samantha S Mann
As global diabetes figures continue to rise, the importance of reducing the burden of macrovascular and microvascular complications of diabetes has never been so great. By 2025 it is estimated that five million people in the UK will have diabetes...
